Skip to main content
. 2019 Sep 19;3(4):311–330. doi: 10.7150/ntno.38954

Scheme 1.

Scheme 1

(a) Construction of the dual-targeting dendrimer-based drug carrier. Reagents and conditions: (i) H2O, room temperature (RT), 30 min; (ii) H2O, RT, 30 min; (iii) H2O, RT, Argon, 1 h; (iv) H2O, RT, Argon, 4 h; (v) stirring in dark place, 24 h. (b) Schematic illustration of glioma targeting therapy across the BBB using the dual-targeting drug delivery system.